Researchers at MIT have developed a microneedle patch for treating alopecia areata, showing promise in early mouse studies. The patch delivers drugs to recalibrate the immune response, preventing it from attacking hair follicles and showing hair regrowth without side effects. This new approach could offer a local, regulated treatment alternative for patients.
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Researchers at MIT have developed a microneedle patch for treating alopecia areata, showing promise in early mouse studies. The patch delivers drugs to recalibrate the immune response, preventing it from attacking hair follicles and showing hair regrowth without side effects. This new approach could offer a local, regulated treatment alternative for patients.
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.
Blog post excerpt [1-2 lines]. This text is automatically pulled from your existing blog post.